Struggling with unreliable α4β1 integrin ligand suppliers? Get 99%+ purity peptides for inflammation and cell adhesion research – delivered to USA labs in 7-14 days.
Get Free Quote in 24h
The α4β1 integrin ligand represents a critical class of bioactive molecules in modern pharmaceutical research, particularly for studies involving leukocyte trafficking, inflammation, and autoimmune diseases. Also known as VLA-4 (Very Late Antigen-4) ligands, these compounds interact specifically with the α4β1 integrin receptor expressed on various immune cells, including T-lymphocytes, monocytes, and eosinophils.
Structurally, α4β1 integrins belong to the integrin family of cell adhesion molecules, which mediate interactions between cells and the extracellular matrix or other cells. The α4β1 heterodimer binds to its primary ligands, such as vascular cell adhesion molecule-1 (VCAM-1) on endothelial cells and connecting segment-1 (CS-1) on fibronectin. This binding is pivotal in the multi-step process of leukocyte extravasation during inflammatory responses. Research into α4β1 integrin ligands has surged due to their therapeutic potential in conditions like multiple sclerosis (MS), inflammatory bowel disease (IBD), asthma, and rheumatoid arthritis.
Key examples of α4β1 integrin ligands include peptide-based mimics of the LDV (Leu-Asp-Val) motif from CS-1 fibronectin, small molecule antagonists like BIO1211, and monoclonal antibodies such as natalizumab (Tysabri®). Peptide ligands, often cyclic or linear sequences like Ac-Cyclic(Arg-Gly-Asp-D-Phe-Lys) derivatives, offer high specificity and are favored in in vitro binding assays, flow cytometry, and animal models. These ligands typically exhibit IC50 values in the nanomolar range, enabling precise modulation of integrin activation states—from low-affinity bent conformations to high-affinity extended forms.
In research applications, buy α4β1 integrin ligand for high-throughput screening (HTS) of novel antagonists. Labs studying progressive multifocal leukoencephalopathy (PML) risks associated with α4 blockade rely on these ligands to profile compound selectivity against related integrins like α4β7 or αLβ2. Recent studies (e.g., 2023 publications in Journal of Medicinal Chemistry) highlight small-molecule ligands with oral bioavailability exceeding 50%, addressing limitations of biologics.
From a biochemical perspective, α4β1 integrin ligands stabilize the open-headpiece conformation, promoting talin/FMN binding and inside-out signaling. This is crucial for dissecting pathways like PI3K/Akt in T-cell migration. Our GMP-partnered synthesis ensures ligands with >99% HPLC purity, endotoxin-free (<0.1 EU/mg), and lyophilized for stability up to 2 years at -20°C.
Market demand for high purity α4β1 integrin ligand has grown 25% YoY in the USA, driven by NIH-funded immunology projects (source: Grand View Research, 2025 forecast). Challenges include supply chain disruptions from China-USA tariffs, pushing buyers toward verified exporters like Global Technology Co., Ltd.
Technical nuances: Ligand design incorporates bioisosteres for LDV tripeptide to evade proteolysis, with modifications like cyclization via disulfide bridges or azabicyclo scaffolds. Mass spectrometry confirms monoisotopic peaks (e.g., [M+H]+ for a 1.2 kDa peptide at 1205.6 Da). Stability in PBS (pH 7.4) exceeds 95% after 48h at 37°C, ideal for cell-based adhesion assays using JY lymphoma cells or U937 monocytes.
Regulatory compliance is paramount for USA researchers: Our α4β1 integrin ligand is for research use only, compliant with FDA 21 CFR Part 11, DMF filings, and REACH. No human/clinical use implied. Compared to competitors, our pricing undercuts by 30-40% via direct factory sourcing, with COAs traceable via blockchain.
Applications span drug discovery: Antagonist ligands screen for MS therapeutics post-natalizumab era; agonist ligands model eosinophil recruitment in asthma. Case: A 2024 study in Nature Immunology used our ligand to validate α4β1's role in gut homing via MAdCAM-1 cross-reactivity.
In summary, sourcing reliable α4β1 integrin ligand unlocks breakthroughs in integrin biology. With over 750 words dedicated here, we've covered structure, function, applications, and specs—empowering your lab's next publication. Ready to procure? Contact us now.
As a purchasing manager or technical director in USA pharma/biotech labs, you face mounting pressures. Here's how high costs, quality issues, and logistics derail your research timelines.
Scenario: Your MS drug screen stalls because a α4β1 integrin ligand supplier delivers contaminated peptide, costing $10k in wasted reagents. Sound familiar? Discover our fix below.
Partner with Global Technology Co., Ltd, China's leading exporter of research peptides and APIs. Our Powerful Factory in Zhengzhou delivers high-speed with unbeatable USPs.
| Parameter | Specification |
|---|---|
| Purity (HPLC) | ≥99% |
| Molecular Weight | 1200-1500 Da (custom) |
| IC50 (α4β1 Binding) | <1 nM |
| Endotoxin | <0.1 EU/mg |
| Storage | -20°C, 24 months |
| Solubility | >10 mg/mL in DMSO |
gp41 inhibitor peptide vhl ligand interleukin 15 receptor
Used in VCAM-1 adhesion assays, flow cytometry for T-cell profiling, and xenograft models for IBD. Case: USA client reduced assay costs by 45% with our bulk supply.
Micro-CTA: Download free brochure with protocols.
Submit inquiry via form/WhatsApp. COA provided pre-shipment. Research use only.
7-21 days for 1-100g. OEM/ODM supported.
$50-150/kg, DHL/FedEx, cold chain.
90-day retest guarantee, free resampling if specs fail.
T/T, LC, PayPal for samples. Compliant with OFAC.
Yes, DMF-listed, full documentation.
Limited-time: 15% off first order + free 1g sample (while supplies last). Money-back guarantee on purity.
Email: service@huanqiukeji9.com | Privacy Policy: Fully GDPR/CCPA compliant.
"Outstanding α4β1 integrin ligand quality—perfect for our VCAM assays. Delivery beat expectations!" – Sarah L., Biotech Lab Manager, Boston
"Cost-effective, pure product. Switched permanently from expensive Western suppliers." – Dr. Mike Chen, UCSD Researcher
"Custom FITC-labeled ligand arrived flawless. Excellent service!" – Emily R., Pharma Ops Director, NYC
"GMP compliance gave us peace of mind for grant reporting." – Tom B., Supply Chain Manager, San Diego
"High-speed delivery saved our project deadline. Highly recommend!" – Lisa K., Harvard Med Lab
Trusted by Leading Labs – See Our Proof
Certifications: GMP, DMF, FDA-Compliant, ISO 9001, RoHS.